# Retrospective Study Evaluating the Contribution of Rheopheresis in the Treatment of Uremic Calciphylaxis (RHEO-CUA)

> **NCT05633121** · — · COMPLETED · sponsor: **Association ECHO** · enrollment: 55 (actual)

## Conditions studied

- Rheopheresis
- Calcifying Uremic Arteriolopathy
- Uremic Calciphylaxis

## Interventions

- **PROCEDURE:** Rheopheresis

## Key facts

- **NCT ID:** NCT05633121
- **Lead sponsor:** Association ECHO
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-20
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-09-30
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2023-12-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05633121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05633121, "Retrospective Study Evaluating the Contribution of Rheopheresis in the Treatment of Uremic Calciphylaxis (RHEO-CUA)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05633121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*